APO Research
Talk to an analyst

APO RESEARCH · REPORT

Point-of-Care Testing (POCT)

Point-of-care (POC) is defined as medical testing at or near the site of patient care. The driving notion behind POCT is to bring the test conveniently and immediately to the patient. This increases the likelihood that the patient, physician, and care team will receive the results quicker, which allows for immediate clinical management decisions to be made.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Point-of-care (POC) is defined as medical testing at or near the site of patient care. The driving notion behind POCT is to bring the test conveniently and immediately to the patient. This increases the likelihood that the patient, physician, and care team will receive the results quicker, which allows for immediate clinical management decisions to be made.

Selected research

Industry Research

Point-of-Care Testing (POCT) Industry Research Report 2026

21 December 2025149 pages

Choose your research edition.

Industry ResearchPoint-of-Care Testing (POCT) Industry Research Report 2026149 pages · $2,950 USDIndustry Growth & TrendsGlobal Point-of-Care Testing (POCT) Industry Growth and Trends Forecast to 2032125 pages · $3,450 USDMarket StructureGlobal Point-of-Care Testing (POCT) Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032193 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Point-of-Care Testing (POCT) Market Outlook and Growth Opportunities 2026214 pages · $4,250 USDMarket Analysis & ForecastGlobal Point-of-Care Testing (POCT) Market Analysis and Forecast 2026-2032211 pages · $4,950 USD

Market perspective

Point-of-care (POC) is defined as medical testing at or near the site of patient care. The driving notion behind POCT is to bring the test conveniently and immediately to the patient. This increases the likelihood that the patient, physician, and care team will receive the results quicker, which allows for immediate clinical management decisions to be made.

Global Point-of-Care Testing (POCT) main players are Roche, Abbott, Johnson & Johnson, etc. Global top three manufacturers hold a share over 45%. North America is the largest market, with a share nearly 40%.

Report Scope

Read the full market overview

This report quantifies the global Point-of-Care Testing (POCT) market in terms of revenue (US$ million) and, where applicable, sales volume (M Units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.

It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/M Units) and concentration ratios (CR5/CR10).

The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.

Key Companies & Market Share Insights

This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.

Point-of-Care Testing (POCT) Market by Company

Roche

Abbott

Johnson & Johnson

Siemens Healthcare

Danaher

Ascensia

Bio-Rad Laboratories

BioMerieux

ARKRAY

Nova Biomedical

Trividia Health

Quidel

Accriva

OraSure Technologies

Helena Laboratories

A. Menarini Diagnostics

Abaxis (Zoetis)

Ortho Clinical Diagnostics

Phamatech

Chembio Diagnostics

Trinity Biotech

ELITech Group

Response Biomedical

Princeton BioMeditech

Alfa Wassermann

Point-of-Care Testing (POCT) Segment by Type

Blood Glucose Testing

Infectious Diseases Testing

Cardiac Markers Testing

Coagulation Testing

Pregnancy and Fertility Testing

Blood Gas/Electrolytes Testing

Urinalysis Testing

Point-of-Care Testing (POCT) Segment by Application

Clinics

Hospitals

Laboratory

Others

Point-of-Care Testing (POCT) Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Point-of-Care Testing (POCT) market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Point-of-Care Testing (POCT) and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Point-of-Care Testing (POCT).

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Research objectives, research methods, data sources, data cross-validation;

Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 3: Detailed analysis of Point-of-Care Testing (POCT) manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.

Chapter 5: Production/output, value of Point-of-Care Testing (POCT) by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.

Chapter 6: Consumption of Point-of-Care Testing (POCT) in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.

Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 11: The main points and conclusions of the report.

More report detail

Tables and figures
List of Tables Table 1. Secondary Sources Table 2. Primary Sources Table 3. Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Market Value Comparison by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 5. Global Point-of-Care Testing (POCT) Volume and Revenue Market Size and CAGR of Manufacturers (2021 Versus 2025) Table 6. Global Point-of-Care Testing (POCT) Sales (M Units) of Manufacturers (2021-2026) Table 7. Global Point-of-Care Testing (POCT) Sales Market Share by Manufacturers (2021-2026) Table 8. Global Point-of-Care Testing (POCT) Revenue of Manufacturers (2021-2026) Table 9. Global Point-of-Care Testing (POCT) Revenue Share by Manufacturers (2021-2026) Table 10. Global Market Point-of-Care Testing (POCT) Average Price (USD/Unit) of Manufacturers (2021-2026) Table 11. Global Point-of-Care Testing (POCT) Industry Ranking, 2024 VS 2025 VS 2026 Table 12. Global Manufacturers of Point-of-Care Testing (POCT), Manufacturing Sites & Headquarters Table 13. Global Manufacturers of Point-of-Care Testing (POCT), Product Type & Application Table 14. Global Point-of-Care Testing (POCT) Manufacturers Established Date Table 15. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 16. Global Point-of-Care Testing (POCT) by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 17. Manufacturers Mergers & Acquisitions, Expansion Plans) Table 18. Roche Company Information Table 19. Roche Business Overview Table 20. Roche Point-of-Care Testing (POCT) Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 21. Roche Point-of-Care Testing (POCT) Product Portfolio Table 22. Roche Recent Developments Table 23. Abbott Company Information Table 24. Abbott Business Overview Table 25. Abbott Point-of-Care Testing (POCT) Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 26. Abbott Point-of-Care Testing (POCT) Product Portfolio Table 27. Abbott Recent Developments Table 28. Johnson & Johnson Company Information Table 29. Johnson & Johnson Business Overview Table 30. Johnson & Johnson Point-of-Care Testing (POCT) Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 31. Johnson & Johnson Point-of-Care Testing (POCT) Product Portfolio Table 32. Johnson & Johnson Recent Developments Table 33. Siemens Healthcare Company Information Table 34. Siemens Healthcare Business Overview Table 35. Siemens Healthcare Point-of-Care Testing (POCT) Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 36. Siemens Healthcare Point-of-Care Testing (POCT) Product Portfolio Table 37. Siemens Healthcare Recent Developments Table 38. Danaher Company Information Table 39. Danaher Business Overview Table 40. Danaher Point-of-Care Testing (POCT) Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 41. Danaher Point-of-Care Testing (POCT) Product Portfolio Table 42. Danaher Recent Developments Table 43. Ascensia Company Information Table 44. Ascensia Business Overview Table 45. Ascensia Point-of-Care Testing (POCT) Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 46. Ascensia Point-of-Care Testing (POCT) Product Portfolio Table 47. Ascensia Recent Developments Table 48. Bio-Rad Laboratories Company Information Table 49. Bio-Rad Laboratories Business Overview Table 50. Bio-Rad Laboratories Point-of-Care Testing (POCT) Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 51. Bio-Rad Laboratories Point-of-Care Testing (POCT) Product Portfolio Table 52. Bio-Rad Laboratories Recent Developments Table 53. BioMerieux Company Information Table 54. BioMerieux Business Overview Table 55. BioMerieux Point-of-Care Testing (POCT) Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 56. BioMerieux Point-of-Care Testing (POCT) Product Portfolio Table 57. BioMerieux Recent Developments Table 58. ARKRAY Company Information Table 59. ARKRAY Business Overview Table 60. ARKRAY Point-of-Care Testing (POCT) Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 61. ARKRAY Point-of-Care Testing (POCT) Product Portfolio Table 62. ARKRAY Recent Developments Table 63. Nova Biomedical Company Information Table 64. Nova Biomedical Business Overview Table 65. Nova Biomedical Point-of-Care Testing (POCT) Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 66. Nova Biomedical Point-of-Care Testing (POCT) Product Portfolio Table 67. Nova Biomedical Recent Developments Table 68. Trividia Health Company Information Table 69. Trividia Health Business Overview Table 70. Trividia Health Point-of-Care Testing (POCT) Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 71. Trividia Health Point-of-Care Testing (POCT) Product Portfolio Table 72. Trividia Health Recent Developments Table 73. Quidel Company Information Table 74. Quidel Business Overview Table 75. Quidel Point-of-Care Testing (POCT) Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 76. Quidel Point-of-Care Testing (POCT) Product Portfolio Table 77. Quidel Recent Developments Table 78. Accriva Company Information Table 79. Accriva Business Overview Table 80. Accriva Point-of-Care Testing (POCT) Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 81. Accriva Point-of-Care Testing (POCT) Product Portfolio Table 82. Accriva Recent Developments Table 83. OraSure Technologies Company Information Table 84. OraSure Technologies Business Overview Table 85. OraSure Technologies Point-of-Care Testing (POCT) Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 86. OraSure Technologies Point-of-Care Testing (POCT) Product Portfolio Table 87. OraSure Technologies Recent Developments Table 88. Helena Laboratories Company Information Table 89. Helena Laboratories Business Overview Table 90. Helena Laboratories Point-of-Care Testing (POCT) Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 91. Helena Laboratories Point-of-Care Testing (POCT) Product Portfolio Table 92. Helena Laboratories Recent Developments Table 93. A. Menarini Diagnostics Company Information Table 94. A. Menarini Diagnostics Business Overview Table 95. A. Menarini Diagnostics Point-of-Care Testing (POCT) Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 96. A. Menarini Diagnostics Point-of-Care Testing (POCT) Product Portfolio Table 97. A. Menarini Diagnostics Recent Developments Table 98. Abaxis (Zoetis) Company Information Table 99. Abaxis (Zoetis) Business Overview Table 100. Abaxis (Zoetis) Point-of-Care Testing (POCT) Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 101. Abaxis (Zoetis) Point-of-Care Testing (POCT) Product Portfolio Table 102. Abaxis (Zoetis) Recent Developments Table 103. Ortho Clinical Diagnostics Company Information Table 104. Ortho Clinical Diagnostics Business Overview Table 105. Ortho Clinical Diagnostics Point-of-Care Testing (POCT) Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 106. Ortho Clinical Diagnostics Point-of-Care Testing (POCT) Product Portfolio Table 107. Ortho Clinical Diagnostics Recent Developments Table 108. Phamatech Company Information Table 109. Phamatech Business Overview Table 110. Phamatech Point-of-Care Testing (POCT) Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 111. Phamatech Point-of-Care Testing (POCT) Product Portfolio Table 112. Phamatech Recent Developments Table 113. Chembio Diagnostics Company Information Table 114. Chembio Diagnostics Business Overview Table 115. Chembio Diagnostics Point-of-Care Testing (POCT) Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 116. Chembio Diagnostics Point-of-Care Testing (POCT) Product Portfolio Table 117. Chembio Diagnostics Recent Developments Table 118. Trinity Biotech Company Information Table 119. Trinity Biotech Business Overview Table 120. Trinity Biotech Point-of-Care Testing (POCT) Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 121. Trinity Biotech Point-of-Care Testing (POCT) Product Portfolio Table 122. Trinity Biotech Recent Developments Table 123. ELITech Group Company Information Table 124. ELITech Group Business Overview Table 125. ELITech Group Point-of-Care Testing (POCT) Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 126. ELITech Group Point-of-Care Testing (POCT) Product Portfolio Table 127. ELITech Group Recent Developments Table 128. Response Biomedical Company Information Table 129. Response Biomedical Business Overview Table 130. Response Biomedical Point-of-Care Testing (POCT) Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 131. Response Biomedical Point-of-Care Testing (POCT) Product Portfolio Table 132. Response Biomedical Recent Developments Table 133. Princeton BioMeditech Company Information Table 134. Princeton BioMeditech Business Overview Table 135. Princeton BioMeditech Point-of-Care Testing (POCT) Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 136. Princeton BioMeditech Point-of-Care Testing (POCT) Product Portfolio Table 137. Princeton BioMeditech Recent Developments Table 138. Alfa Wassermann Company Information Table 139. Alfa Wassermann Business Overview Table 140. Alfa Wassermann Point-of-Care Testing (POCT) Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 141. Alfa Wassermann Point-of-Care Testing (POCT) Product Portfolio Table 142. Alfa Wassermann Recent Developments Table 143. Global Point-of-Care Testing (POCT) Market Size by Region (US$ Million): 2021 VS 2025 VS 2032 Table 144. Global Point-of-Care Testing (POCT) Sales by Region (2021-2026) & (M Units) Table 145. Global Point-of-Care Testing (POCT) Sales Market Share by Region (2021-2026) Table 146. Global Point-of-Care Testing (POCT) Sales by Region (2027-2032) & (M Units) Table 147. Global Point-of-Care Testing (POCT) Sales Market Share by Region (2027-2032) Table 148. Global Point-of-Care Testing (POCT) Revenue by Region (2021-2026) & (US$ Million) Table 149. Global Point-of-Care Testing (POCT) Revenue Market Share by Region (2021-2026) Table 150. Global Point-of-Care Testing (POCT) Revenue by Region (2027-2032) & (US$ Million) Table 151. Global Point-of-Care Testing (POCT) Revenue Market Share by Region (2027-2032) Table 152. North America Point-of-Care Testing (POCT) Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 153. North America Point-of-Care Testing (POCT) Sales by Country (2021-2026) & (M Units) Table 154. North America Point-of-Care Testing (POCT) Sales by Country (2027-2032) & (M Units) Table 155. North America Point-of-Care Testing (POCT) Revenue by Country (2021-2026) & (US$ Million) Table 156. North America Point-of-Care Testing (POCT) Revenue by Country (2027-2032) & (US$ Million) Table 157. Europe Point-of-Care Testing (POCT) Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 158. Europe Point-of-Care Testing (POCT) Sales by Country (2021-2026) & (M Units) Table 159. Europe Point-of-Care Testing (POCT) Sales by Country (2027-2032) & (M Units) Table 160. Europe Point-of-Care Testing (POCT) Revenue by Country (2021-2026) & (US$ Million) Table 161. Europe Point-of-Care Testing (POCT) Revenue by Country (2027-2032) & (US$ Million) Table 162. Asia Pacific Point-of-Care Testing (POCT) Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 163. Asia Pacific Point-of-Care Testing (POCT) Sales by Country (2021-2026) & (M Units) Table 164. Asia Pacific Point-of-Care Testing (POCT) Sales by Country (2027-2032) & (M Units) Table 165. Asia Pacific Point-of-Care Testing (POCT) Revenue by Country (2021-2026) & (US$ Million) Table 166. Asia Pacific Point-of-Care Testing (POCT) Revenue by Country (2027-2032) & (US$ Million) Table 167. South America Point-of-Care Testing (POCT) Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 168. South America Point-of-Care Testing (POCT) Sales by Country (2021-2026) & (M Units) Table 169. South America Point-of-Care Testing (POCT) Sales by Country (2027-2032) & (M Units) Table 170. South America Point-of-Care Testing (POCT) Revenue by Country (2021-2026) & (US$ Million) Table 171. South America Point-of-Care Testing (POCT) Revenue by Country (2027-2032) & (US$ Million) Table 172. Middle East and Africa Point-of-Care Testing (POCT) Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 173. Middle East and Africa Point-of-Care Testing (POCT) Sales by Country (2021-2026) & (M Units) Table 174. Middle East and Africa Point-of-Care Testing (POCT) Sales by Country (2027-2032) & (M Units) Table 175. Middle East and Africa Point-of-Care Testing (POCT) Revenue by Country (2021-2026) & (US$ Million) Table 176. Middle East and Africa Point-of-Care Testing (POCT) Revenue by Country (2027-2032) & (US$ Million) Table 177. Global Point-of-Care Testing (POCT) Sales by Type (2021-2026) & (M Units) Table 178. Global Point-of-Care Testing (POCT) Sales by Type (2027-2032) & (M Units) Table 179. Global Point-of-Care Testing (POCT) Sales Market Share by Type (2021-2026) Table 180. Global Point-of-Care Testing (POCT) Sales Market Share by Type (2027-2032) Table 181. Global Point-of-Care Testing (POCT) Revenue by Type (2021-2026) & (US$ Million) Table 182. Global Point-of-Care Testing (POCT) Revenue by Type (2027-2032) & (US$ Million) Table 183. Global Point-of-Care Testing (POCT) Revenue Market Share by Type (2021-2026) Table 184. Global Point-of-Care Testing (POCT) Revenue Market Share by Type (2027-2032) Table 185. Global Point-of-Care Testing (POCT) Price by Type (2021-2026) & (USD/Unit) Table 186. Global Point-of-Care Testing (POCT) Price by Type (2027-2032) & (USD/Unit) Table 187. Global Point-of-Care Testing (POCT) Sales by Application (2021-2026) & (M Units) Table 188. Global Point-of-Care Testing (POCT) Sales by Application (2027-2032) & (M Units) Table 189. Global Point-of-Care Testing (POCT) Sales Market Share by Application (2021-2026) Table 190. Global Point-of-Care Testing (POCT) Sales Market Share by Application (2027-2032) Table 191. Global Point-of-Care Testing (POCT) Revenue by Application (2021-2026) & (US$ Million) Table 192. Global Point-of-Care Testing (POCT) Revenue by Application (2027-2032) & (US$ Million) Table 193. Global Point-of-Care Testing (POCT) Revenue Market Share by Application (2021-2026) Table 194. Global Point-of-Care Testing (POCT) Revenue Market Share by Application (2027-2032) Table 195. Global Point-of-Care Testing (POCT) Price by Application (2021-2026) & (USD/Unit) Table 196. Global Point-of-Care Testing (POCT) Price by Application (2027-2032) & (USD/Unit) Table 197. Key Raw Materials Table 198. Raw Materials Key Suppliers Table 199. Point-of-Care Testing (POCT) Distributors List Table 200. Point-of-Care Testing (POCT) Customers List Table 201. Point-of-Care Testing (POCT) Industry Trends Table 202. Point-of-Care Testing (POCT) Industry Drivers Table 203. Point-of-Care Testing (POCT) Industry Restraints Table 204. Authors List of This Report List of Figures Figure 1. Research Methodology Figure 2. Research Process Figure 3. Key Executives Interviewed Figure 4. Point-of-Care Testing (POCT) Product Image Figure 5. Global Point-of-Care Testing (POCT) Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 6. Global Point-of-Care Testing (POCT) Market Size (2021-2032) & (US$ Million) Figure 7. Global Point-of-Care Testing (POCT) Sales (2021-2032) & (M Units) Figure 8. Global Point-of-Care Testing (POCT) Average Price (USD/Unit) & (2021-2032) Figure 9. Blood Glucose Testing Product Image Figure 10. Infectious Diseases Testing Product Image Figure 11. Cardiac Markers Testing Product Image Figure 12. Coagulation Testing Product Image Figure 13. Pregnancy and Fertility Testing Product Image Figure 14. Blood Gas/Electrolytes Testing Product Image Figure 15. Urinalysis Testing Product Image Figure 16. Clinics Product Image Figure 17. Hospitals Product Image Figure 18. Laboratory Product Image Figure 19. Others Product Image Figure 20. Global Point-of-Care Testing (POCT) Revenue Share by Manufacturers in 2025 Figure 21. Global Manufacturers of Point-of-Care Testing (POCT), Manufacturing Sites & Headquarters Figure 22. Global Top 5 and 10 Point-of-Care Testing (POCT) Players Market Share by Revenue in 2025 Figure 23. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 24. Global Point-of-Care Testing (POCT) Market Size by Region (US$ Million): 2021 VS 2025 VS 2032 Figure 25. Global Point-of-Care Testing (POCT) Sales by Region in 2025 Figure 26. Global Point-of-Care Testing (POCT) Revenue by Region in 2025 Figure 27. North America Point-of-Care Testing (POCT) Market Size by Country in 2025 Figure 28. North America Point-of-Care Testing (POCT) Sales Market Share by Country (2021-2032) Figure 29. North America Point-of-Care Testing (POCT) Revenue Market Share by Country (2021-2032) Figure 30. United States Point-of-Care Testing (POCT) Revenue Growth Rate (2021-2032) & (US$ Million) Figure 31. Canada Point-of-Care Testing (POCT) Revenue Growth Rate (2021-2032) & (US$ Million) Figure 32. Mexico Point-of-Care Testing (POCT) Revenue Growth Rate (2021-2032) & (US$ Million) Figure 33. Europe Point-of-Care Testing (POCT) Market Size by Country in 2025 Figure 34. Europe Point-of-Care Testing (POCT) Sales Market Share by Country (2021-2032) Figure 35. Europe Point-of-Care Testing (POCT) Revenue Market Share by Country (2021-2032) Figure 36. Germany Point-of-Care Testing (POCT) Revenue Growth Rate (2021-2032) & (US$ Million) Figure 37. France Point-of-Care Testing (POCT) Revenue Growth Rate (2021-2032) & (US$ Million) Figure 38. U.K. Point-of-Care Testing (POCT) Revenue Growth Rate (2021-2032) & (US$ Million) Figure 39. Italy Point-of-Care Testing (POCT) Revenue Growth Rate (2021-2032) & (US$ Million) Figure 40. Russia Point-of-Care Testing (POCT) Revenue Growth Rate (2021-2032) & (US$ Million) Figure 41. Spain Point-of-Care Testing (POCT) Revenue Growth Rate (2021-2032) & (US$ Million) Figure 42. Netherlands Point-of-Care Testing (POCT) Revenue Growth Rate (2021-2032) & (US$ Million) Figure 43. Switzerland Point-of-Care Testing (POCT) Revenue Growth Rate (2021-2032) & (US$ Million) Figure 44. Sweden Point-of-Care Testing (POCT) Revenue Growth Rate (2021-2032) & (US$ Million) Figure 45. Poland Point-of-Care Testing (POCT) Revenue Growth Rate (2021-2032) & (US$ Million) Figure 46. Asia Pacific Point-of-Care Testing (POCT) Market Size by Country in 2025 Figure 47. Asia Pacific Point-of-Care Testing (POCT) Sales Market Share by Country (2021-2032) Figure 48. Asia Pacific Point-of-Care Testing (POCT) Revenue Market Share by Country (2021-2032) Figure 49. China Point-of-Care Testing (POCT) Revenue Growth Rate (2021-2032) & (US$ Million) Figure 50. Japan Point-of-Care Testing (POCT) Revenue Growth Rate (2021-2032) & (US$ Million) Figure 51. South Korea Point-of-Care Testing (POCT) Revenue Growth Rate (2021-2032) & (US$ Million) Figure 52. India Point-of-Care Testing (POCT) Revenue Growth Rate (2021-2032) & (US$ Million) Figure 53. Australia Point-of-Care Testing (POCT) Revenue Growth Rate (2021-2032) & (US$ Million) Figure 54. Taiwan Point-of-Care Testing (POCT) Revenue Growth Rate (2021-2032) & (US$ Million) Figure 55. Southeast Asia Point-of-Care Testing (POCT) Revenue Growth Rate (2021-2032) & (US$ Million) Figure 56. Southeast Asia Point-of-Care Testing (POCT) Revenue Growth Rate (2021-2032) & (US$ Million) Figure 57. South America Point-of-Care Testing (POCT) Market Size by Country in 2025 Figure 58. South America Point-of-Care Testing (POCT) Sales Market Share by Country (2021-2032) Figure 59. South America Point-of-Care Testing (POCT) Revenue Market Share by Country (2021-2032) Figure 60. Brazil Point-of-Care Testing (POCT) Revenue Growth Rate (2021-2032) & (US$ Million) Figure 61. Argentina Point-of-Care Testing (POCT) Revenue Growth Rate (2021-2032) & (US$ Million) Figure 62. Chile Point-of-Care Testing (POCT) Revenue Growth Rate (2021-2032) & (US$ Million) Figure 63. Colombia Point-of-Care Testing (POCT) Revenue Growth Rate (2021-2032) & (US$ Million) Figure 64. Middle East and Africa Point-of-Care Testing (POCT) Market Size by Country in 2025 Figure 65. Middle East and Africa Point-of-Care Testing (POCT) Sales Market Share by Country (2021-2032) Figure 66. Middle East and Africa Point-of-Care Testing (POCT) Revenue Market Share by Country (2021-2032) Figure 67. Egypt Point-of-Care Testing (POCT) Revenue Growth Rate (2021-2032) & (US$ Million) Figure 68. South Africa Point-of-Care Testing (POCT) Revenue Growth Rate (2021-2032) & (US$ Million) Figure 69. Israel Point-of-Care Testing (POCT) Revenue Growth Rate (2021-2032) & (US$ Million) Figure 70. Türkiye Point-of-Care Testing (POCT) Revenue Growth Rate (2021-2032) & (US$ Million) Figure 71. GCC Countries Point-of-Care Testing (POCT) Revenue Growth Rate (2021-2032) & (US$ Million) Figure 72. Global Point-of-Care Testing (POCT) Sales Market Share by Type (2021-2032) Figure 73. Global Point-of-Care Testing (POCT) Revenue Market Share by Type (2021-2032) Figure 74. Global Point-of-Care Testing (POCT) Price (USD/Unit) by Type (2021-2032) Figure 75. Global Point-of-Care Testing (POCT) Sales Market Share by Application (2021-2032) Figure 76. Global Point-of-Care Testing (POCT) Revenue Market Share by Application (2021-2032) Figure 77. Global Point-of-Care Testing (POCT) Price (USD/Unit) by Application (2021-2032) Figure 78. Point-of-Care Testing (POCT) Value Chain Figure 79. Point-of-Care Testing (POCT) Production Mode & Process Figure 80. Direct Comparison with Distribution Share Figure 81. Distributors Profiles Figure 82. Point-of-Care Testing (POCT) Industry Opportunities and Challenges

Scope & coverage.

Types
  • Blood Glucose Testing
  • Infectious Diseases Testing
  • Cardiac Markers Testing
  • Coagulation Testing
  • Pregnancy and Fertility Testing
  • Blood Gas/Electrolytes Testing
  • Urinalysis Testing
Applications
  • Clinics
  • Hospitals
  • Laboratory
  • Others
Companies covered
  • Roche
  • Abbott
  • Johnson & Johnson
  • Siemens Healthcare
  • Danaher
  • Ascensia
  • Bio-Rad Laboratories
  • BioMerieux
  • ARKRAY
  • Nova Biomedical
  • Trividia Health
  • Quidel
  • Accriva
  • OraSure Technologies
  • Helena Laboratories
  • A. Menarini Diagnostics
  • Abaxis (Zoetis)
  • Ortho Clinical Diagnostics
  • Phamatech
  • Chembio Diagnostics
  • Trinity Biotech
  • ELITech Group
  • Response Biomedical
  • Princeton BioMeditech
  • Alfa Wassermann

Inside the report.

1 Preface
  1. 1.1 Scope of Report
  2. 1.2 Reasons for Doing This Study
  3. 1.3 Research Methodology
  4. 1.4 Research Process
  5. 1.5 Data Source
  6. 1.5.1 Secondary Sources
  7. 1.5.2 Primary Sources
2 Market Overview
  1. 2.1 Product Definition
  2. 2.2 Global Market Growth Prospects
  3. 2.2.1 Global Point-of-Care Testing (POCT) Market Size (2021-2032)
  4. 2.2.2 Global Point-of-Care Testing (POCT) Sales (2021-2032)
  5. 2.2.3 Global Point-of-Care Testing (POCT) Market Average Price (2021-2032)
  6. 2.3 Point-of-Care Testing (POCT) by Type
  7. 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
  8. 2.3.2 Blood Glucose Testing
  9. 2.3.3 Infectious Diseases Testing
  10. 2.3.4 Cardiac Markers Testing
  11. 2.3.5 Coagulation Testing
  12. 2.3.6 Pregnancy and Fertility Testing
  13. 2.3.7 Blood Gas/Electrolytes Testing
  14. 2.3.8 Urinalysis Testing
  15. 2.4 Point-of-Care Testing (POCT) by Application
  16. 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
  17. 2.4.2 Clinics
  18. 2.4.3 Hospitals
  19. 2.4.4 Laboratory
  20. 2.4.5 Others
3 Market Competitive Landscape by Manufacturers
  1. 3.1 Global Point-of-Care Testing (POCT) Market Competitive Situation by Manufacturers (2021 Versus 2025)
  2. 3.2 Global Point-of-Care Testing (POCT) Sales (M Units) of Manufacturers (2021-2026)
  3. 3.3 Global Point-of-Care Testing (POCT) Revenue of Manufacturers (2021-2026)
  4. 3.4 Global Point-of-Care Testing (POCT) Average Price by Manufacturers (2021-2026)
  5. 3.5 Global Point-of-Care Testing (POCT) Industry Ranking, 2024 VS 2025 VS 2026
  6. 3.6 Global Manufacturers of Point-of-Care Testing (POCT), Manufacturing Sites & Headquarters
  7. 3.7 Global Manufacturers of Point-of-Care Testing (POCT), Product Type & Application
  8. 3.8 Global Manufacturers of Point-of-Care Testing (POCT), Established Date
  9. 3.9 Global Point-of-Care Testing (POCT) Market CR5 and HHI
  10. 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
  1. 4.1 Roche
  2. 4.1.1 Roche Company Information
  3. 4.1.2 Roche Business Overview
  4. 4.1.3 Roche Point-of-Care Testing (POCT) Sales, Revenue and Gross Margin (2021-2026)
  5. 4.1.4 Roche Point-of-Care Testing (POCT) Product Portfolio
  6. 4.1.5 Roche Recent Developments
  7. 4.2 Abbott
  8. 4.2.1 Abbott Company Information
  9. 4.2.2 Abbott Business Overview
  10. 4.2.3 Abbott Point-of-Care Testing (POCT) Sales, Revenue and Gross Margin (2021-2026)
  11. 4.2.4 Abbott Point-of-Care Testing (POCT) Product Portfolio
  12. 4.2.5 Abbott Recent Developments
  13. 4.3 Johnson & Johnson
  14. 4.3.1 Johnson & Johnson Company Information
  15. 4.3.2 Johnson & Johnson Business Overview
  16. 4.3.3 Johnson & Johnson Point-of-Care Testing (POCT) Sales, Revenue and Gross Margin (2021-2026)
  17. 4.3.4 Johnson & Johnson Point-of-Care Testing (POCT) Product Portfolio
  18. 4.3.5 Johnson & Johnson Recent Developments
  19. 4.4 Siemens Healthcare
  20. 4.4.1 Siemens Healthcare Company Information
  21. 4.4.2 Siemens Healthcare Business Overview
  22. 4.4.3 Siemens Healthcare Point-of-Care Testing (POCT) Sales, Revenue and Gross Margin (2021-2026)
  23. 4.4.4 Siemens Healthcare Point-of-Care Testing (POCT) Product Portfolio
  24. 4.4.5 Siemens Healthcare Recent Developments
  25. 4.5 Danaher
  26. 4.5.1 Danaher Company Information
  27. 4.5.2 Danaher Business Overview
  28. 4.5.3 Danaher Point-of-Care Testing (POCT) Sales, Revenue and Gross Margin (2021-2026)
  29. 4.5.4 Danaher Point-of-Care Testing (POCT) Product Portfolio
  30. 4.5.5 Danaher Recent Developments
  31. 4.6 Ascensia
  32. 4.6.1 Ascensia Company Information
  33. 4.6.2 Ascensia Business Overview
  34. 4.6.3 Ascensia Point-of-Care Testing (POCT) Sales, Revenue and Gross Margin (2021-2026)
  35. 4.6.4 Ascensia Point-of-Care Testing (POCT) Product Portfolio
  36. 4.6.5 Ascensia Recent Developments
  37. 4.7 Bio-Rad Laboratories
  38. 4.7.1 Bio-Rad Laboratories Company Information
  39. 4.7.2 Bio-Rad Laboratories Business Overview
  40. 4.7.3 Bio-Rad Laboratories Point-of-Care Testing (POCT) Sales, Revenue and Gross Margin (2021-2026)
  41. 4.7.4 Bio-Rad Laboratories Point-of-Care Testing (POCT) Product Portfolio
  42. 4.7.5 Bio-Rad Laboratories Recent Developments
  43. 4.8 BioMerieux
  44. 4.8.1 BioMerieux Company Information
  45. 4.8.2 BioMerieux Business Overview
  46. 4.8.3 BioMerieux Point-of-Care Testing (POCT) Sales, Revenue and Gross Margin (2021-2026)
  47. 4.8.4 BioMerieux Point-of-Care Testing (POCT) Product Portfolio
  48. 4.8.5 BioMerieux Recent Developments
  49. 4.9 ARKRAY
  50. 4.9.1 ARKRAY Company Information
  51. 4.9.2 ARKRAY Business Overview
  52. 4.9.3 ARKRAY Point-of-Care Testing (POCT) Sales, Revenue and Gross Margin (2021-2026)
  53. 4.9.4 ARKRAY Point-of-Care Testing (POCT) Product Portfolio
  54. 4.9.5 ARKRAY Recent Developments
  55. 4.10 Nova Biomedical
  56. 4.10.1 Nova Biomedical Company Information
  57. 4.10.2 Nova Biomedical Business Overview
  58. 4.10.3 Nova Biomedical Point-of-Care Testing (POCT) Sales, Revenue and Gross Margin (2021-2026)
  59. 4.10.4 Nova Biomedical Point-of-Care Testing (POCT) Product Portfolio
  60. 4.10.5 Nova Biomedical Recent Developments
  61. 4.11 Trividia Health
  62. 4.11.1 Trividia Health Company Information
  63. 4.11.2 Trividia Health Business Overview
  64. 4.11.3 Trividia Health Point-of-Care Testing (POCT) Sales, Revenue and Gross Margin (2021-2026)
  65. 4.11.4 Trividia Health Point-of-Care Testing (POCT) Product Portfolio
  66. 4.11.5 Trividia Health Recent Developments
  67. 4.12 Quidel
  68. 4.12.1 Quidel Company Information
  69. 4.12.2 Quidel Business Overview
  70. 4.12.3 Quidel Point-of-Care Testing (POCT) Sales, Revenue and Gross Margin (2021-2026)
  71. 4.12.4 Quidel Point-of-Care Testing (POCT) Product Portfolio
  72. 4.12.5 Quidel Recent Developments
  73. 4.13 Accriva
  74. 4.13.1 Accriva Company Information
  75. 4.13.2 Accriva Business Overview
  76. 4.13.3 Accriva Point-of-Care Testing (POCT) Sales, Revenue and Gross Margin (2021-2026)
  77. 4.13.4 Accriva Point-of-Care Testing (POCT) Product Portfolio
  78. 4.13.5 Accriva Recent Developments
  79. 4.14 OraSure Technologies
  80. 4.14.1 OraSure Technologies Company Information
  81. 4.14.2 OraSure Technologies Business Overview
  82. 4.14.3 OraSure Technologies Point-of-Care Testing (POCT) Sales, Revenue and Gross Margin (2021-2026)
  83. 4.14.4 OraSure Technologies Point-of-Care Testing (POCT) Product Portfolio
  84. 4.14.5 OraSure Technologies Recent Developments
  85. 4.15 Helena Laboratories
  86. 4.15.1 Helena Laboratories Company Information
  87. 4.15.2 Helena Laboratories Business Overview
  88. 4.15.3 Helena Laboratories Point-of-Care Testing (POCT) Sales, Revenue and Gross Margin (2021-2026)
  89. 4.15.4 Helena Laboratories Point-of-Care Testing (POCT) Product Portfolio
  90. 4.15.5 Helena Laboratories Recent Developments
  91. 4.16 A. Menarini Diagnostics
  92. 4.16.1 A. Menarini Diagnostics Company Information
  93. 4.16.2 A. Menarini Diagnostics Business Overview
  94. 4.16.3 A. Menarini Diagnostics Point-of-Care Testing (POCT) Sales, Revenue and Gross Margin (2021-2026)
  95. 4.16.4 A. Menarini Diagnostics Point-of-Care Testing (POCT) Product Portfolio
  96. 4.16.5 A. Menarini Diagnostics Recent Developments
  97. 4.17 Abaxis (Zoetis)
  98. 4.17.1 Abaxis (Zoetis) Company Information
  99. 4.17.2 Abaxis (Zoetis) Business Overview
  100. 4.17.3 Abaxis (Zoetis) Point-of-Care Testing (POCT) Sales, Revenue and Gross Margin (2021-2026)
  101. 4.17.4 Abaxis (Zoetis) Point-of-Care Testing (POCT) Product Portfolio
  102. 4.17.5 Abaxis (Zoetis) Recent Developments
  103. 4.18 Ortho Clinical Diagnostics
  104. 4.18.1 Ortho Clinical Diagnostics Company Information
  105. 4.18.2 Ortho Clinical Diagnostics Business Overview
  106. 4.18.3 Ortho Clinical Diagnostics Point-of-Care Testing (POCT) Sales, Revenue and Gross Margin (2021-2026)
  107. 4.18.4 Ortho Clinical Diagnostics Point-of-Care Testing (POCT) Product Portfolio
  108. 4.18.5 Ortho Clinical Diagnostics Recent Developments
  109. 4.19 Phamatech
  110. 4.19.1 Phamatech Company Information
  111. 4.19.2 Phamatech Business Overview
  112. 4.19.3 Phamatech Point-of-Care Testing (POCT) Sales, Revenue and Gross Margin (2021-2026)
  113. 4.19.4 Phamatech Point-of-Care Testing (POCT) Product Portfolio
  114. 4.19.5 Phamatech Recent Developments
  115. 4.20 Chembio Diagnostics
  116. 4.20.1 Chembio Diagnostics Company Information
  117. 4.20.2 Chembio Diagnostics Business Overview
  118. 4.20.3 Chembio Diagnostics Point-of-Care Testing (POCT) Sales, Revenue and Gross Margin (2021-2026)
  119. 4.20.4 Chembio Diagnostics Point-of-Care Testing (POCT) Product Portfolio
  120. 4.20.5 Chembio Diagnostics Recent Developments
  121. 4.21 Trinity Biotech
  122. 4.21.1 Trinity Biotech Company Information
  123. 4.21.2 Trinity Biotech Business Overview
  124. 4.21.3 Trinity Biotech Point-of-Care Testing (POCT) Sales, Revenue and Gross Margin (2021-2026)
  125. 4.21.4 Trinity Biotech Point-of-Care Testing (POCT) Product Portfolio
  126. 4.21.5 Trinity Biotech Recent Developments
  127. 4.22 ELITech Group
  128. 4.22.1 ELITech Group Company Information
  129. 4.22.2 ELITech Group Business Overview
  130. 4.22.3 ELITech Group Point-of-Care Testing (POCT) Sales, Revenue and Gross Margin (2021-2026)
  131. 4.22.4 ELITech Group Point-of-Care Testing (POCT) Product Portfolio
  132. 4.22.5 ELITech Group Recent Developments
  133. 4.23 Response Biomedical
  134. 4.23.1 Response Biomedical Company Information
  135. 4.23.2 Response Biomedical Business Overview
  136. 4.23.3 Response Biomedical Point-of-Care Testing (POCT) Sales, Revenue and Gross Margin (2021-2026)
  137. 4.23.4 Response Biomedical Point-of-Care Testing (POCT) Product Portfolio
  138. 4.23.5 Response Biomedical Recent Developments
  139. 4.24 Princeton BioMeditech
  140. 4.24.1 Princeton BioMeditech Company Information
  141. 4.24.2 Princeton BioMeditech Business Overview
  142. 4.24.3 Princeton BioMeditech Point-of-Care Testing (POCT) Sales, Revenue and Gross Margin (2021-2026)
  143. 4.24.4 Princeton BioMeditech Point-of-Care Testing (POCT) Product Portfolio
  144. 4.24.5 Princeton BioMeditech Recent Developments
  145. 4.25 Alfa Wassermann
  146. 4.25.1 Alfa Wassermann Company Information
  147. 4.25.2 Alfa Wassermann Business Overview
  148. 4.25.3 Alfa Wassermann Point-of-Care Testing (POCT) Sales, Revenue and Gross Margin (2021-2026)
  149. 4.25.4 Alfa Wassermann Point-of-Care Testing (POCT) Product Portfolio
  150. 4.25.5 Alfa Wassermann Recent Developments
5 Global Point-of-Care Testing (POCT) Market Scenario by Region
  1. 5.1 Global Point-of-Care Testing (POCT) Market Size by Region: 2021 VS 2025 VS 2032
  2. 5.2 Global Point-of-Care Testing (POCT) Sales by Region: 2021-2032
  3. 5.2.1 Global Point-of-Care Testing (POCT) Sales by Region: 2021-2026
  4. 5.2.2 Global Point-of-Care Testing (POCT) Sales by Region: 2027-2032
  5. 5.3 Global Point-of-Care Testing (POCT) Revenue by Region: 2021-2032
  6. 5.3.1 Global Point-of-Care Testing (POCT) Revenue by Region: 2021-2026
  7. 5.3.2 Global Point-of-Care Testing (POCT) Revenue by Region: 2027-2032
  8. 5.4 North America Point-of-Care Testing (POCT) Market Facts & Figures by Country
  9. 5.4.1 North America Point-of-Care Testing (POCT) Market Size by Country: 2021 VS 2025 VS 2032
  10. 5.4.2 North America Point-of-Care Testing (POCT) Sales by Country (2021-2032)
  11. 5.4.3 North America Point-of-Care Testing (POCT) Revenue by Country (2021-2032)
  12. 5.4.4 United States
  13. 5.4.5 Canada
  14. 5.4.6 Mexico
  15. 5.5 Europe Point-of-Care Testing (POCT) Market Facts & Figures by Country
  16. 5.5.1 Europe Point-of-Care Testing (POCT) Market Size by Country: 2021 VS 2025 VS 2032
  17. 5.5.2 Europe Point-of-Care Testing (POCT) Sales by Country (2021-2032)
  18. 5.5.3 Europe Point-of-Care Testing (POCT) Revenue by Country (2021-2032)
  19. 5.5.4 Germany
  20. 5.5.5 France
  21. 5.5.6 U.K.
  22. 5.5.7 Italy
  23. 5.5.8 Russia
  24. 5.5.9 Spain
  25. 5.5.10 Netherlands
  26. 5.5.11 Switzerland
  27. 5.5.12 Sweden
  28. 5.5.13 Poland
  29. 5.6 Asia Pacific Point-of-Care Testing (POCT) Market Facts & Figures by Country
  30. 5.6.1 Asia Pacific Point-of-Care Testing (POCT) Market Size by Country: 2021 VS 2025 VS 2032
  31. 5.6.2 Asia Pacific Point-of-Care Testing (POCT) Sales by Country (2021-2032)
  32. 5.6.3 Asia Pacific Point-of-Care Testing (POCT) Revenue by Country (2021-2032)
  33. 5.6.4 China
  34. 5.6.5 Japan
  35. 5.6.6 South Korea
  36. 5.6.7 India
  37. 5.6.8 Australia
  38. 5.6.9 Taiwan
  39. 5.6.10 Southeast Asia
  40. 5.7 South America Point-of-Care Testing (POCT) Market Facts & Figures by Country
  41. 5.7.1 South America Point-of-Care Testing (POCT) Market Size by Country: 2021 VS 2025 VS 2032
  42. 5.7.2 South America Point-of-Care Testing (POCT) Sales by Country (2021-2032)
  43. 5.7.3 South America Point-of-Care Testing (POCT) Revenue by Country (2021-2032)
  44. 5.7.4 Brazil
  45. 5.7.5 Argentina
  46. 5.7.6 Chile
  47. 5.7.7 Colombia
  48. 5.8 Middle East and Africa Point-of-Care Testing (POCT) Market Facts & Figures by Country
  49. 5.8.1 Middle East and Africa Point-of-Care Testing (POCT) Market Size by Country: 2021 VS 2025 VS 2032
  50. 5.8.2 Middle East and Africa Point-of-Care Testing (POCT) Sales by Country (2021-2032)
  51. 5.8.3 Middle East and Africa Point-of-Care Testing (POCT) Revenue by Country (2021-2032)
  52. 5.8.4 Egypt
  53. 5.8.5 South Africa
  54. 5.8.6 Israel
  55. 5.8.7 Türkiye
  56. 5.8.8 GCC Countries
6 Segment by Type
  1. 6.1 Global Point-of-Care Testing (POCT) Sales by Type (2021-2032)
  2. 6.1.1 Global Point-of-Care Testing (POCT) Sales by Type (2021-2032) & (M Units)
  3. 6.1.2 Global Point-of-Care Testing (POCT) Sales Market Share by Type (2021-2032)
  4. 6.2 Global Point-of-Care Testing (POCT) Revenue by Type (2021-2032)
  5. 6.2.1 Global Point-of-Care Testing (POCT) Sales by Type (2021-2032) & (US$ Million)
  6. 6.2.2 Global Point-of-Care Testing (POCT) Revenue Market Share by Type (2021-2032)
  7. 6.3 Global Point-of-Care Testing (POCT) Price by Type (2021-2032)
7 Segment by Application
  1. 7.1 Global Point-of-Care Testing (POCT) Sales by Application (2021-2032)
  2. 7.1.1 Global Point-of-Care Testing (POCT) Sales by Application (2021-2032) & (M Units)
  3. 7.1.2 Global Point-of-Care Testing (POCT) Sales Market Share by Application (2021-2032)
  4. 7.2 Global Point-of-Care Testing (POCT) Revenue by Application (2021-2032)
  5. 7.2.1 Global Point-of-Care Testing (POCT) Sales by Application (2021-2032) & (US$ Million)
  6. 7.2.2 Global Point-of-Care Testing (POCT) Revenue Market Share by Application (2021-2032)
  7. 7.3 Global Point-of-Care Testing (POCT) Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
  1. 8.1 Point-of-Care Testing (POCT) Value Chain Analysis
  2. 8.1.1 Point-of-Care Testing (POCT) Key Raw Materials
  3. 8.1.2 Raw Materials Key Suppliers
  4. 8.1.3 Point-of-Care Testing (POCT) Production Mode & Process
  5. 8.2 Point-of-Care Testing (POCT) Sales Channels Analysis
  6. 8.2.1 Direct Comparison with Distribution Share
  7. 8.2.2 Point-of-Care Testing (POCT) Distributors
  8. 8.2.3 Point-of-Care Testing (POCT) Customers
9 Global Point-of-Care Testing (POCT) Analyzing Market Dynamics
  1. 9.1 Point-of-Care Testing (POCT) Industry Trends
  2. 9.2 Point-of-Care Testing (POCT) Industry Drivers
  3. 9.3 Point-of-Care Testing (POCT) Industry Opportunities and Challenges
  4. 9.4 Point-of-Care Testing (POCT) Industry Restraints
10 Report Conclusion
    11 Disclaimer

      GET THE RESEARCH

      Choose your license.

      Choose who needs access.
      All options are for this report and research series.

      Compare access permissions.

      Single User License
      One named user. Individual access.
      Multi User License
      Up to 5 users in the same department.
      Enterprise License
      Organization-wide access within the agreed license.

      Access applies to the purchased edition. Later editions are separate purchases.

      License options
      $2,950USD
      Buy now

      PDF by email within 3–5 working days after payment confirmation.

      Talk to an analyst
      APO Research
      Talk to an analyst